Philippe Muller
20Patents
4h-index
18Co-inventors
60Inventor score
Filing activity: May 26, 1998 → Oct 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6037350A | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives | Emerging Cross-Sectional Technologies | 55 | Expired |
| US6169096A | Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives | Emerging Cross-Sectional Technologies | 54 | Expired |
| US6420387B1 | Farnesyl protein transferase inhibiting (imidazol-5-yl) methyl-2-quinolinone derivatives | Emerging Cross-Sectional Technologies | 46 | Expired |
| US9556176B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 29 | Active |
| US7449463B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 4 | Expired |
| US8034835B2 | 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs | Chemistry; Metallurgy | 3 | Active |
| US10266543B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 2 | Active |
| US10280180B2 | Macrocyclic purines for the treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US10280167B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US9725432B2 | Pyrimidine derivatives for the treatment of bacterial diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US10829494B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
| US7176327B2 | Photoreactive compounds and compositions | Human Necessities | 0 | Expired |
| US8883837B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US8278455B2 | 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US10221157B2 | Pyrimidine derivatives for the treatment of bacterial diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US7928097B2 | Photoreactive compounds and compositions | Human Necessities | 0 | Active |
| US11702426B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
| US7884215B2 | 2-substituted benzimidazoles | Chemistry; Metallurgy | 0 | Active |
| US8044073B2 | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US8178694B2 | Heterocyclylaminoalkyl substituted benzimidazoles | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.